Johnson & Johnson’s Rybrevant shows positive effects in difficult-to-treat colorectal cancer
Colorectal cancer accounts for around 10% of all cancer cases globally, with an increase in diagnoses in younger people
Read More
Section: Research
Lilly announces new study data on Inluriyo in metastatic breast cancer
The five-year survival rate for metastatic breast cancer is 30%
Read More
Galderma’s Nemluvio rapidly relieves atopic dermatitis and prurigo nodularis symptoms
Some patients found the treatment reduced itch and sleep disturbance within just two days
Read More
Nektar Therapeutics announces top-line results from alopecia areata study
This autoimmune disease causes hair loss in both women and men, affecting 160 million people worldwide
Read More
Medicus Pharma completes patient enrolment for basal cell carcinoma trial
Interim results have shown over 60% clinical clearance in patients treated with SkinJect
Read More